Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome
scientific article published on February 2013
Author/s
author: Laurence Zitvogel, Nathalie Chaput, Sylvie Rusakiewicz, Axel Le Cesne, Vichnou Poirier-Colame, Clara Locher, Caroline Flament, Alexander M. M. Eggermont, Caroline Robert, Jean-Charles Soria, Michelle Rosenzwajg, Angelo Paci, David Klatzmann
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.